Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,860 | 45,310 | 26,940 | 38,100 | 43,050 |
| Marketable Securities | 0 | 0 | 0 | 0 | 560 |
| Receivables | 1,230 | 3,450 | 3,370 | 3,430 | 3,730 |
| Inventories | 4,050 | 3,750 | 3,490 | 4,410 | 3,390 |
| Other current assets | 2,110 | 2,120 | 3,530 | 3,070 | 4,010 |
| TOTAL | $47,250 | $54,630 | $37,330 | $49,010 | $54,740 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 30,240 | 27,560 | 30,740 | 32,880 | 42,130 |
| TOTAL | $30,240 | $27,560 | $30,740 | $32,880 | $42,130 |
| Total Assets | $80,860 | $85,510 | $71,970 | $86,260 | $103,610 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 50 | 50 | 50 | 50 | 50 |
| Accounts payable and accrued liabilities | 8,740 | 9,710 | 8,690 | 8,150 | 10,460 |
| Accrued Expenses | 0 | 0 | 0 | 3,760 | 0 |
| Other current liabilities | 4,560 | 4,540 | 5,490 | 6,320 | 11,710 |
| TOTAL | $13,370 | $14,840 | $14,830 | $19,260 | $23,070 |
| Non-Current Liabilities | |||||
| Long Term Debt | 80 | 110 | 110 | 140 | 140 |
| Other Non-Current Liabilities | 11,890 | 10,490 | 11,340 | 11,700 | 10,700 |
| TOTAL | $52,690 | $48,150 | $53,950 | $57,750 | $88,520 |
| Total Liabilities | $66,060 | $63,000 | $68,800 | $77,030 | $111,600 |
| Shareholders' Equity | |||||
| Common Shares | 59,630 | 59,620 | 41,200 | 41,200 | 37,400 |
| Retained earnings | -148,010 | -137,860 | -133,410 | -127,530 | -139,570 |
| Other shareholders' equity | 103,170 | 100,740 | 95,380 | 95,550 | 94,190 |
| TOTAL | $14,790 | $22,500 | $3,170 | $9,220 | $-7,980 |
| Total Liabilities And Equity | $80,850 | $85,500 | $71,970 | $86,250 | $103,620 |